Evidence map›Paper›PMID 34943012›Full record

ReviewAntioxidants (Basel, Switzerland)2021

NADPH Oxidase and Epidermal Growth Factor Receptor Are Promising Targets of Phytochemicals for Ultraviolet-Induced Skin Carcinogenesis.

Min Jeong Kim, Su Jeong Ha, Bo Ram So, Chang-Kil Kim, Kyung-Min Kim, Sung Keun Jung

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Functionalization of Nanomaterials for Skin Cancer Theranostics.Frontiers in bioengineering and biotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Min Jeong KimSchool of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.
Su Jeong HaDepartment of Agricultural Biotechnology, Seoul National University, Seoul 08826, Korea.
Bo Ram SoSchool of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.
Chang-Kil KimDepartment of Horticultural Science, Kyungpook National University, Daegu 41566, Korea.
Kyung-Min KimDivision of Plant Biosciences, School of Applied Biosciences, College of Agriculture and Life Science, Kyungpook National University, Daegu 41566, Korea.ORCID 0000-0003-4812-6297
Sung Keun JungSchool of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.
Kyungpook National University · KRSeoul National University · KR

Funding

National Research Foundation of Korea 2021R1F1A1062889
6 · The paper itself

Abstract

The skin acts as the primary defense organ that protects the body from the external environment. Skin cancer is one of the most common cancers in the world. Skin carcinogenesis is usually caused by cell degeneration due to exposure to ultraviolet (UV) radiation, which causes changes in various signaling networks, disrupting the homeostasis of single skin cells. In this review, we summarize the roles of nicotinamide adenine dinucleotide phosphate oxidase (NOX) and epidermal growth factor receptor (EGFR) in UV-induced skin carcinogenesis. Furthermore, we describe the crosstalk that exists between NOX, EGFR, and protein tyrosine phosphatase κ and its oncogenic downstream signaling pathways. Chemoprevention is the use of chemical compounds to recover the healthy status of the skin or delay cancer development. Current evidence from in vitro and in vivo studies on chemopreventive phytochemicals that target NOX, EGFR, or both, as major regulators of skin carcinogenesis will also be discussed.

Indexed as

epidermal growth factor receptor (EGFR)nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase)protein tyrosine phosphatase κ (PTPκ)reactive oxygen species (ROS)

Identifiers

PMID34943012
PMCPMC8750051
OpenAlexW3216482308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.